Cập nhật pháp chế22 thg 9, 2026•1 phút đọc

FDA Approves ANDA076850 for Terconazole Vaginal Suppository

Tác giả: đội ngũ PharmaCountry

FDA granted approval (ANDA076850) for Fougera Pharms' terconazole 80 mg vaginal suppository, now listed as discontinued.

The U.S. Food and Drug Administration has approved an Abbreviated New Drug Application (ANDA) numbered ANDA076850 for a terconazole vaginal suppository. The product, marketed by Fougera Pharms, is a 80 mg terconazole suppository intended for vaginal administration. The submission was an original (ORIG) filing and received approval on July 12, 2006. FDA records indicate the product’s marketing status is listed as discontinued.

Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: FDA.gov

Chủ đề:#ANDA #Terconazole #Vaginal Suppository #FDA #Regulatory Approval #discontinued